Aline Fusco Fares, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy Analysis of Neoadjuvant Treatment in Lung Cancer Using Low-dose Nivolumab Combined With Chemotherapy (NCT06667154) | Aline Fusco Fares, MD | 2023-10-10 |
Track Aline Fusco Fares, MD automatically
Every clearance here is in the API, with alerts when new ones post.